Scholar Rock Holding Corp (SRRK)
15.10
+0.14
(+0.97%)
USD |
NASDAQ |
May 02, 16:00
15.10
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2022 | 47.30M |
| December 31, 2021 | 18.82M |
| September 30, 2021 | 18.20M |
| June 30, 2021 | 15.78M |
| March 31, 2021 | 15.08M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.40M |
| September 30, 2020 | 19.54M |
| June 30, 2020 | 21.28M |
| March 31, 2020 | 22.42M |
| December 31, 2019 | 20.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
15.08M
Minimum
Mar 2021
47.30M
Maximum
Mar 2022
21.43M
Average
19.18M
Median
Revenue (TTM) Benchmarks
| Regeneron Pharmaceuticals Inc | 13.12B |
| Ocular Therapeutix Inc | 58.44M |
| Alpine Immune Sciences Inc | 58.88M |
| Keros Therapeutics Inc | -- |
| X4 Pharmaceuticals Inc | -- |